{"organizations": [], "uuid": "d794d52bbbb0723e9d5b8a7d49f3b4db9e279509", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/abbott-results-preview/abbott-laboratoriesexpected-to-postearnings-of-73cents-a-share-summary-idUSL8N1PH4B7", "country": "US", "domain_rank": 408, "title": "Abbott Laboratories expected to post earnings of 73 cents a share - summary", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-22T20:49:00.000+02:00", "replies_count": 0, "uuid": "d794d52bbbb0723e9d5b8a7d49f3b4db9e279509"}, "author": "", "url": "https://www.reuters.com/article/abbott-results-preview/abbott-laboratoriesexpected-to-postearnings-of-73cents-a-share-summary-idUSL8N1PH4B7", "ord_in_thread": 0, "title": "Abbott Laboratories expected to post earnings of 73 cents a share - summary", "locations": [], "entities": {"persons": [{"name": "abbott", "sentiment": "none"}], "locations": [{"name": "abbott park", "sentiment": "none"}], "organizations": [{"name": "abbott laboratories", "sentiment": "negative"}, {"name": "starmine", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 22, 2018 / 6:50 PM / in 6 minutes Abbott Laboratories expected to post earnings of 73 cents a share - summary Reuters Staff 2 Min Read \nJan 22 (Reuters) - \n* Abbott Laboratories is expected to show a rise in quarterly revenue when it reports results on January 24. \n* The Abbott Park, Illinois-based company is expected to report a 38.5 percent increase in revenue to $7.39 billion from $5.33 billion a year ago, according to the mean estimate of 16 analysts, according to Thomson Reuters data. \n* The analyst mean estimate for Abbott Laboratories is for earnings of 73 cents per share. For the same quarter last year, the company reported earnings of 65 cents per share. \n* The current average analyst rating on the shares is “buy” and the breakdown of recommendations is 16 “strong buy” or “buy,” 5 “hold” and no “sell” or “strong sell.” \n* The Starmine predicted earnings surprise, the difference between Wall Street’s mean estimate and Starmine’s estimate of its highest rated analysts, is positive for Abbott at 0.28 percent; predicted revenue surprise is negative at 0.01 percent. \n* The mean earnings estimate of analysts was unchanged in the last three months. \n* The earnings announcement is scheduled for January 24 at 01:30 p.m. GMT. \n* Abbott Laboratories belongs to the S&P 500. This summary was generated 01:30 p.m. GMT.", "external_links": [], "published": "2018-01-22T20:49:00.000+02:00", "crawled": "2018-01-22T21:01:22.023+02:00", "highlightTitle": ""}